We cannot be caught off guard and risk watching innovative therapies suffocate at the hands of a regulatory system that has not kept up or further cripple the regulatory system by the approval of products that inherently are unsafe.
Burgess emphasizes the need for a responsive regulatory system to support innovative therapies.
Share
More from Michael Burgess
I thank the Representative from New York for yielding me the time. Mr. Speaker, I rise in support of the rule. I rise in support of the underlying bills, in particular, H.R. 9494 to provide continuing funding for the Government of the…
By direction of the Committee on Rules, I call up House Resolution 1341 and ask for its immediate consideration. The Clerk read the resolution, as follows: H. Res. 1341 Resolved, That upon adoption of this resolution it shall be in order…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
I am going to yield to Mr. Alford here in just a moment, but let me yield myself 2 minutes for the purpose of a response. It is difficult for me to sit here and be lectured about the cost of living by the gentleman from Massachusetts…
Other voices in this conversation
